Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease

Annals of Human Biology

Volumn 32, Issue 5, 2005, Pages 620-629

  Duman, Belgin S ^a   Türkoǧlu, Çavlan ^a   Akpinar, Belhhan ^a   Güden, Mustafa ^a   Vertii, Anastassia ^a   Çaǧatay, Penbe ^b   Günay, Demet ^c   Büyükdevrim, A Sevim ^c  

^a KADIR HAS UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

Author keywords

Coronary artery disease; Lipoproteins; Polymorphism

Indexed keywords

APOLIPOPROTEIN B; LIPID;

HEALTH AND DISEASE;

ARTICLE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

APOLIPOPROTEINS B; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TURKEY; VARIATION (GENETICS);

EID: 27844531701     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.1080/03014460500228626     Document Type: Article

References (25)

1. Berg K, Hames C, Dahlen G, Frick MH, Krishan I. 1976. Genetic variation in serum low density lipoproteins and lipid levels in man. Proc Natl Acad Sci USA 73:937-940.
2. Boekholdt SM, Peters RJ, Fountoulaki K, Kastelein JJ, Sijbrands EJ. 2003. Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systemic meta-analysis. Hum Genet 113:417-425.
3. Bohn M, Bakken A, Erikssen J, Berg K. 1993. XbaI polymorphism in DNA at the apolipoprotein B locus is associated with myocardial infarction (MI). Clin Genet 44:241-248.
4. Chan L, Dresel H. 1990. Genetic factors influencing lipoprotein structure: implications for atherosclerosis. Lab Invest 62:522-537.
5. Chiodini BD, Barlera S, Franzosi MG, Beceiro VL, Introna M, Tognoni G. 2003. apo B gene polymorphisms and coronary artery disease: A meta-analysis. Atherosclerosis 167:355-366.
6. Choong ML, Srthi SK, Koay ES. 1999. Effects of intragenic variability at 3 polymorphic sites of the apolipoprotein B gene on serum lipids and lipoproteins in a multiethnic Asian population. Hum Biol 71:381-397.
7. Delghandi M, Thangarajah R, Nilsen M, Grimsgaard S, Bonaa KH, Tonstad S, Jorgensen L. 1999. DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls. Acta Cardiol 54:215-225.
8. Genest JJ, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, Salem DN, Wilson PW, Masharani U, Frossard PM, Schaefer EJ. 1990. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82:7-17.
9. Guzman EC, Hirata MH, Quintao EC, Hirata RD. 2000. Association of the apolipoprotein B gene polymorphisms with cholesterol levels and response to fluvastatin in Brazilian individuals with high risk for coronary heart disease. Clin Chem Lab Med 38:731-736.
10. Gylling H, Kontula K, Koivisto UM, Miettinen HE, Miettinen TA. 1997. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact. Arterioscler Thromb Vasc Biol 17:38-44.
11. Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL. 1986. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 315:1509-1515.
12. Hong SH, Song J, Kim JQ. 2001. The haplotype analyses using multiple markers of the apolipoprotein B gene in patients with coronary artery disease. J Korean Med Sci 16:719-724.
13. Howard BV, Lee ET, Fabsitz RR, Robbins DC, Yeh JL, Cowan LD, Welty TK. 1996. Diabetes and coronary heart disease in American Indians: The Strong Heart Study. Diabetes 45:Suppl. 3, S6-S13.
14. Hubacek JA, Pistulkova H, Pisa Z, Valenta Z, Skodova Z, Poledne R. 1998. Lack of an association between apolipoprotein B XbaI polymorphism and blood lipid parameters in childhood. Physiol Res 47:89-93.
15. Iso H, Harada S, Shimamoto T, Folsom AR, Koike K, Sato S, Iida M, Komachi Y. 1996. Polymorphism of the apolipoprotein B gene and blood lipid concentrations in Japanese and Caucasian population samples. Atherosclerosis 126:233-241.
16. Korhonen T, Savolainen MJ, Kesaniemi YA. 1999. Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia. Atherosclerosis 146:1-10.
17. Ma YH, Schumaker VN, Butler R, Sparkes RS. 1987. Two DNA restriction fragment length polymorphisms associated with Ag(t/z) and Ag(g/c) antigenic sites of human apolipoprotein B. Arteriosclerosis 7:301-305.
18. Machado MO, Hirata MH, Bertolami MC, Hirata RD. 2001. Apo B gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men. J Clin Lab Anal 15:19-24.
19. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 16:1215.
20. Misra A, Nishanth S, Pasha ST, Pandey RM, Sethi P, Rawat DS. 2001. Relationship of Xba1 and EcoR1 polymorphisms of apolipoprotein-B gene to dyslipidemia and obesity in Asian Indians in North India. Indian Heart J 53:177-183.
21. Monsalve MV, Young R, Jobsis J, Wiseman SA, Dhamu S, Powell JT, Greenhalgh RM, Humphries SE. 1988. DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial disease. Atherosclerosis 70:123-129.
22. Myant NB, Gallagher J, Barbir M, Thompson GR, Wile D, Humphries SE. 1989. Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease. Atherosclerosis 77:193-201.
23. Siest G, Henny J, Galteau MM, Schiele F, Steinmetz J, Visvikis S. 1995. Lipid and lipoprotein genetic variability: an important contribution from the French health examination centers. Clin Biochem 28:31-38.
24. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Humphries SE. 1991. Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis 89:69-81.
25. West KM, Ahuja MM, Bennett PH, Czyzyk A, De Acosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K, et al. 1983. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 6:361-369.